Treatment of Refractory Dry Eye Associated With Graft Versus Host Disease With 0.03% Tacrolimus Eyedrops

Journal of Ocular Pharmacology and Therapeutics - United States
doi 10.1089/jop.2012.0265
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Updated Experience With Inolimomab as Treatment for Corticosteroid-Refractory Acute Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2009English

Ruxolitinib as a Promising Treatment for Corticosteroid-Refractory Graft-Versus -Host Disease

British Journal of Haematology
Hematology
2017English

Tocilizumab for Steroid Refractory Acute Graft-Versus-Host Disease

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

Etanercept as Treatment of Steroid-Refractory Acute Graft Versus Host Disease in Pediatric Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

APRIL Levels Are Associated With Disease Activity in Human Chronic Graft-Versus-Host Disease

Haematologica
Hematology
2016English

Graft-Versus-Host Disease

New England Journal of Medicine
Medicine
1991English

Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease With Daclizumab and Etanercept

Bone Marrow Transplantation
TransplantationHematology
2005English

Graft Versus Host Disease

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy